1,3-Benzodioxolylbutanamine

BDB.svg

1,3-Benzodioxolylbutanamine (also known as BDB) is a chemical compound of the substituted amphetamines class. It is structurally related to 3,4-methylenedioxyamphetamine (MDA) and 3,4-methylenedioxymethamphetamine (MDMA), which are well-known psychoactive substances.

Chemical Structure and Properties

1,3-Benzodioxolylbutanamine has a chemical structure that includes a benzodioxole ring attached to a butanamine chain. The IUPAC name for BDB is 1-(1,3-Benzodioxol-5-yl)butan-2-amine. The molecular formula is C₁₁H₁₅N₁O₂.

Pharmacology

BDB acts as a serotonin and dopamine releasing agent. It is known to produce effects similar to those of MDMA, including euphoria, increased empathy, and enhanced sensory perception. However, the potency and duration of BDB's effects are generally considered to be less intense compared to MDMA.

Legal Status

The legal status of BDB varies by country. In some jurisdictions, it may be classified as a controlled substance due to its structural similarity to MDMA and MDA, which are often regulated under drug control laws.

Related Compounds

• 3,4-Methylenedioxyamphetamine (MDA)
• 3,4-Methylenedioxymethamphetamine (MDMA)
• 4-Methylmethcathinone (Mephedrone)
• 2C-B

See Also

• Substituted amphetamines
• Psychoactive drugs
• Serotonin releasing agents

References

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian